Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder.
about
Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@en
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@nl
type
label
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@en
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@nl
prefLabel
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@en
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@nl
P2093
P2860
P356
P1476
Single-Dose Pharmacokinetics o ...... eficit/Hyperactivity Disorder.
@en
P2093
Angus McLean
Ann Childress
Bev Incledon
Jogarao Gobburu
Norberto J DeSousa
Shailly Mehrotra
P2860
P356
10.1089/CAP.2017.0044
P577
2017-10-17T00:00:00Z